Home » VITEX COMPLETES CORPORATE NAME CHANGE TO PANACOS PHARMACEUTICALS, INC.
VITEX COMPLETES CORPORATE NAME CHANGE TO PANACOS PHARMACEUTICALS, INC.
V.I. Technologies, Inc. (Nasdaq: VITX) ("Vitex" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the completion of the change of its corporate name to Panacos Pharmaceuticals, Inc. Effective today, the Company will trade on the NASDAQ National Market under the new ticker symbol PANC.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-18-2005/0004090566&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May